The World Health Organization (WHO) announced that clinical trials for two potential Ebola treatments will begin next week in the Democratic Republic of Congo (DRC). The trials will focus on the most virulent strain of the Ebola virus currently affecting the region. Preparations for the study are now complete, according to the WHO Director-General. This initiative represents a crucial step forward in the search for effective therapies against the deadly disease. The trials aim to assess the safety and efficacy of the two treatments in a real-world setting. Results from the study are expected to inform future treatment protocols and potentially save lives during outbreaks. The DRC has been battling ongoing Ebola outbreaks, making this research particularly vital.